These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

833 related items for PubMed ID: 29630692

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
    Rotem-Kohavi N, Williams LJ, Virji-Babul N, Bjornson BH, Brain U, Werker JF, Grunau RE, Miller SP, Oberlander TF.
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A Prospective Study Evaluating the Effects of SSRI Exposure on Cardiac Size and Function in Newborns.
    Ansah DA, Reinking BE, Colaizy TT, Roghair RD, Haskell SE.
    Neonatology; 2019 Jan; 115(4):320-327. PubMed ID: 30836356
    [Abstract] [Full Text] [Related]

  • 6. Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants.
    Rotem-Kohavi N, Williams LJ, Muller AM, Abdi H, Virji-Babul N, Bjornson BH, Brain U, Werker JF, Grunau RE, Miller SP, Oberlander TF.
    Depress Anxiety; 2019 Aug; 36(8):753-765. PubMed ID: 31066992
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy.
    Oberlander TF, Reebye P, Misri S, Papsdorf M, Kim J, Grunau RE.
    Arch Pediatr Adolesc Med; 2007 Jan; 161(1):22-9. PubMed ID: 17199063
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL, O'Grady KE, Battle CL, Wisner KL, Anderson GM, Stroud LR, Miller-Loncar CL, Young ME, Lester BM.
    Am J Psychiatry; 2016 Feb 01; 173(2):147-57. PubMed ID: 26514656
    [Abstract] [Full Text] [Related]

  • 11. Intrauterine Exposure to Antidepressants or Maternal Depressive Symptoms and Offspring Brain White Matter Trajectories From Late Childhood to Adolescence.
    Koc D, El Marroun H, Stricker BH, Muetzel RL, Tiemeier H.
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Feb 01; 9(2):217-226. PubMed ID: 37926188
    [Abstract] [Full Text] [Related]

  • 12. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS, Gyllenberg D, Malm H, McKeague IW, Hinkka-Yli-Salomäki S, Artama M, Gissler M, Cheslack-Postava K, Weissman MM, Gingrich JA, Sourander A.
    JAMA Psychiatry; 2016 Nov 01; 73(11):1163-1170. PubMed ID: 27732704
    [Abstract] [Full Text] [Related]

  • 13. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
    Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.
    Arch Gen Psychiatry; 2006 Aug 01; 63(8):898-906. PubMed ID: 16894066
    [Abstract] [Full Text] [Related]

  • 14. Early neurological outcome of young infants exposed to selective serotonin reuptake inhibitors during pregnancy: results from the observational SMOK study.
    de Vries NK, van der Veere CN, Reijneveld SA, Bos AF.
    PLoS One; 2013 Aug 01; 8(5):e64654. PubMed ID: 23785389
    [Abstract] [Full Text] [Related]

  • 15. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
    Oberlander TF, Grunau RE, Fitzgerald C, Papsdorf M, Rurak D, Riggs W.
    Pediatrics; 2005 Feb 01; 115(2):411-25. PubMed ID: 15687451
    [Abstract] [Full Text] [Related]

  • 16. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R, Bar-Oz B, Gorelik E, Reif S, Perlman A, Matok I.
    Am J Obstet Gynecol; 2019 Jan 01; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [Abstract] [Full Text] [Related]

  • 17. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.
    Am J Psychiatry; 2012 Nov 01; 169(11):1165-74. PubMed ID: 23128923
    [Abstract] [Full Text] [Related]

  • 18. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
    Pawluski JL, Galea LA, Brain U, Papsdorf M, Oberlander TF.
    Pediatrics; 2009 Oct 01; 124(4):e662-70. PubMed ID: 19786426
    [Abstract] [Full Text] [Related]

  • 19. Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.
    Gur TL, Kim DR, Epperson CN.
    Psychopharmacology (Berl); 2013 Jun 01; 227(4):567-82. PubMed ID: 23681158
    [Abstract] [Full Text] [Related]

  • 20. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
    Ng QX, Venkatanarayanan N, Ho CYX, Sim WS, Lim DY, Yeo WS.
    J Womens Health (Larchmt); 2019 Mar 01; 28(3):331-338. PubMed ID: 30407100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.